Treatment-Resistant Depression Management and Outcomes
Summary
Treatment-resistant depression (TRD) encompasses cases of major depressive disorder that fail to remit after two or more adequate courses of pharmacotherapy. It poses a substantial clinical challenge owing to its high prevalence, heterogeneity and associated burden. Management strategies extend beyond conventional antidepressants to include augmentation with other psychotropic agents, structured psychotherapy, neurostimulation techniques and, in selected cases, experimental or personalised approaches informed by genetic or biomarker profiles. Outcomes in TRD are generally poorer than in treatment-responsive depression, with higher rates of chronicity, comorbidity, functional impairment, health-care utilisation, mortality and reduced quality of life. Timely identification of patients at risk of resistance, application of staging models and prognostic tools can guide the sequencing of interventions. Emerging evidence supports the integration of multidisciplinary care, the use of predictive analytics for individualising treatment choice and the adoption of health-economic models to inform resource allocation. Globally, TRD management strategies must balance efficacy, tolerability and accessibility, emphasising adherence, monitoring and stepped care to optimise long-term outcomes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Treatment-Resistant Depression Management and Outcomes publication trend
The graph below shows the total number of articles in treatment-resistant depression management and outcomes across all publications each year (not limited to Nature Index journals).
Technical terms
Treatment-resistant depression (TRD): Major depressive disorder that fails to respond to at least two adequate antidepressant trials of different pharmacological classes.
Neuromodulation: Therapeutic alteration of nervous system activity through methods such as vagus nerve stimulation or transcranial magnetic stimulation.
Prognostic model: A statistical tool combining clinical and demographic variables to predict the likelihood of an outcome, such as progression to TRD.
Polygenic risk score: An aggregate measure of genetic liability based on the sum of risk alleles weighted by their effect sizes for a particular trait.
Markov cohort model: A mathematical simulation that represents disease progression through defined health states over discrete time intervals to estimate outcomes such as costs and mortality.
References
- Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study. JAMA Psychiatry (2023).
- Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial. Brain Stimulation (2024).
- Projecting the 10-year costs of care and mortality burden of depression until 2032: a Markov modelling study developed from real-world data. The Lancet Regional Health - Western Pacific (2024).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.